
Alfuzosin Hydrochloride
Commercial active pharmaceutical ingredient for benign prostatic hyperplasia / benign prostatic hypertrophy.
Product overview
CAS RN:
81403-68-1
Therapeutic area:
Benign prostatic hyperplasia / benign prostatic hypertrophy
API category:
Non-sterile small-molecule API
Manufacturing site:
CZECH-GEN, a.s., Czech Republic
Product status:
Commercial API
Regulatory status
CEP:
Available
ASMF:
Available
US DMF:
Available
Other markets supported:
Available
Supply information
Typical commercial batch size:
40–50 kg
Minimum order quantity:
10 kg
Sample availability:
Available upon request
Standard lead time:
2–3 weeks when the material is in stock
Available documentation
GMP certificate:
Download hereResidual solvents statement:
Available upon request
Change notification policy:
Available upon request
Get in touch
Contact
Interested in a partnership, career opportunity or media information? Contact us and we will connect you with the right person.



















